Form 4 for RNTX Rein Therapeutics, Inc.

Accepted 2024-12-09 00:00:00 ET · period of report 2024-12-05 · accession 0000950170-24-134522 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2024-12-09	2024-12-05	RNTX	WINDSOR JAMES BRIAN	Pres, CEO	P - Purchase	$2.24	+400	161	New	+$897.61

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-12-05	P	A	239	$2.24	239	I By son	—	—	(F1) The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
2	Common	Common Stock	2024-12-05	P	A	161	$2.25	161	I By son	—	—	(F1) The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.